Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 18, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Tumour ablation: technical aspects.

Gerlig Widmann1, Gerd Bodner, Reto Bale

  • 1Department for Microinvasive Therapy, Department of Radiology, Innsbruck Medical University, Innsbruck, Austria.

Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|December 8, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report.

JTO clinical and research reports·2026
Same author

Lung nodule detection and potential impact on guideline-based management: a retrospective post-market evaluation of three commercial software systems.

European radiology·2026
Same author

Stereotactic Percutaneous Thermal Ablation of Primary and Metastatic Liver Tumors: A Prospective Registry-Based Study.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Biological Cardiovascular Age Derived from Coronary CTA Reports Using a Large Language Model: A Novel Predictor of Major Adverse Cardiovascular Events?

Diagnostics (Basel, Switzerland)·2026
Same author

International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.

The Lancet. Oncology·2026
Same author

International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.

The Lancet. Oncology·2026
Same journal

When PSMA is not enough: the diagnostic blind spots of PSMA PET/CT and the added value of [¹⁸F]FDG in high-risk prostate cancer: dual-tracer cohort study.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Evaluation of audiovisual and auditory interventions on exam anxiety during whole-body magnetic resonance imaging in cancer patients: a quasi-experimental study.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Correction to: [¹⁸F]PSMA-1007 and [¹⁸F]FDG PET/CT in patients with metastatic triple-negative breast cancer: a prospective head-to-head comparison and assessment of PSMA-targeted radioligand therapy applicability.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

MRI-based perfusion-diffusion habitat analysis for characterizing intratumoral heterogeneity in rectal adenocarcinoma.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Survival prediction of <sup>18</sup>F-FDG PET/CT in pediatric patients with recurrent neuroblastoma.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
See all related articles

Image-guided radiofrequency ablation (RFA) offers a minimally invasive option for liver tumors. Achieving complete tumor ablation with adequate margins is crucial for preventing recurrence and improving survival rates.

Area of Science:

  • Interventional Radiology
  • Oncology
  • Medical Device Technology

Background:

  • Image-guided percutaneous radiofrequency ablation (RFA) is a minimally invasive procedure for tumor treatment.
  • Complete ablation of liver tumors, including a margin of healthy tissue, is critical for local recurrence and survival rates.
  • Various RFA devices and techniques exist, requiring careful planning for optimal outcomes.

Purpose of the Study:

  • To review the current state-of-the-art in percutaneous RFA for liver tumors.
  • To examine different RFA device technologies, approaches, and treatment strategies.
  • To highlight the importance of accurate planning and individualized strategies for RFA of liver tumors.

Main Methods:

  • Literature review of percutaneous radiofrequency ablation for liver tumors.

More Related Videos

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Related Experiment Videos

Last Updated: Jun 18, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

  • Analysis of current RFA device technologies and their application.
  • Evaluation of treatment strategies and approaches for liver tumor ablation.

    • Main Results:

    • The effectiveness of RFA depends on achieving complete ablation with sufficient margins.
    • Predicting ablation necrosis configuration and extent is essential for interventionalists.
    • Individualized treatment strategies are necessary for tumors near vital structures.

    Conclusions:

    • Percutaneous RFA is a viable treatment for liver tumors.
    • Optimal RFA outcomes require precise planning, execution, and appropriate device selection.
    • Further advancements in RFA technology and strategies aim to improve patient outcomes.